Need help finding what you are looking for?
Contact Us
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1702474
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1702474
Respiratory Care Devices Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)
PUBLISHED:
PAGES: 290 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global respiratory care devices market, valued at USD 23.3 billion in 2024, is expected to grow at a CAGR of 8.2%, reaching USD 43.5 billion by 2032. The market's expansion is driven by the rising burden of respiratory diseases, particularly in aging populations and regions with high tobacco use. Technological innovations, including the integration of IoT in monitoring devices and telemedicine services, are also accelerating growth. Furthermore, regulatory frameworks and healthcare infrastructure improvements across regions are contributing to the growing adoption of respiratory care devices in hospitals and homecare settings.
Key Insights
Segmentation: The market is divided into therapeutic, monitoring, and diagnostic devices. Therapeutic devices dominate, with significant demand for ventilators, oxygen concentrators, and CPAP machines.
Regional Trends: North America holds the largest market share, driven by advanced healthcare infrastructure and high prevalence of respiratory diseases. The Asia-Pacific region is anticipated to be the fastest-growing due to rising healthcare investments and increased incidence of respiratory conditions.
Technological Advancements: The integration of IoT and AI in respiratory care devices is revolutionizing the sector by enabling continuous monitoring and real-time data sharing with healthcare providers, improving patient outcomes.
Competitive Landscape: Key players such as Philips Healthcare, ResMed, and Medtronic are leading the market. Competition is intensifying with emerging players focusing on portable and affordable devices for homecare settings.
Rising Disease Burden: The increasing incidence of chronic diseases, particularly COPD, asthma, and sleep apnea, combined with environmental factors like urbanization and pollution, is significantly driving demand for respiratory care devices.
Regulatory Challenges: Strict medical device regulations, though ensuring safety and quality, present challenges in the timely market entry of new products. Regulatory bodies like the FDA and EMA play a critical role in device approval processes.
Homecare Growth: The growing preference for home-based care is boosting demand for portable respiratory devices, contributing to market expansion. The trend aligns with the increase in telemedicine and digital health services.
Product Code: 10222
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
- 5.4. Growth Opportunities in Global Respiratory Care Devices Market
- 5.5. Pricing Analysis
- 5.6. Technology Analysis
- 5.7. Go-To Market Strategy
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2023)
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Product Benchmarking of Key Players
- 6.5. Recent Strategic Developments
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Type (2019-2030)
- 7.3. Market Revenue, by Application (2019-2030)
- 7.3.1. Therapeutic market revenue, by type (2019-2030)
- 7.3.2. Monitoring market revenue, by type (2019-2030)
- 7.3.3. Diagnostic market revenue, by type (2019-2030)
- 7.4. Market Revenue, by End User (2019-2030)
- 7.5. Market Revenue, by Region (2019-2030)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Type (2019-2030)
- 8.3. Market Revenue, by Application (2019-2030)
- 8.3.1. Therapeutic market revenue, by type (2019-2030)
- 8.3.2. Monitoring market revenue, by type (2019-2030)
- 8.3.3. Diagnostic market revenue, by type (2019-2030)
- 8.4. Market Revenue, by End User (2019-2030)
- 8.5. Market Revenue, by Country (2019-2030)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Type (2019-2030)
- 9.3. Market Revenue, by Application (2019-2030)
- 9.3.1. Therapeutic market revenue, by type (2019-2030)
- 9.3.2. Monitoring market revenue, by type (2019-2030)
- 9.3.3. Diagnostic market revenue, by type (2019-2030)
- 9.4. Market Revenue, by End User (2019-2030)
- 9.5. Market Revenue, by Country (2019-2030)
Chapter 10. APAC Market
- 10.1. Overview
- 10.2. Market Revenue, by Type (2019-2030)
- 10.3. Market Revenue, by Application (2019-2030)
- 10.3.1. Therapeutic market revenue, by type (2019-2030)
- 10.3.2. Monitoring market revenue, by type (2019-2030)
- 10.3.3. Diagnostic market revenue, by type (2019-2030)
- 10.4. Market Revenue, by End User (2019-2030)
- 10.5. Market Revenue, by Country (2019-2030)
Chapter 11. LATAM Market
- 11.1. Overview
- 11.2. Market Revenue, by Type (2019-2030)
- 11.3. Market Revenue, by Application (2019-2030)
- 11.3.1. Therapeutic market revenue, by type (2019-2030)
- 11.3.2. Monitoring market revenue, by type (2019-2030)
- 11.3.3. Diagnostic market revenue, by type (2019-2030)
- 11.4. Market Revenue, by End User (2019-2030)
- 11.5. Market Revenue, by Country (2019-2030)
Chapter 12. MEA Market
- 12.1. Overview
- 12.2. Market Revenue, by Type (2019-2030)
- 12.3. Market Revenue, by Application (2019-2030)
- 12.3.1. Therapeutic market revenue, by type (2019-2030)
- 12.3.2. Monitoring market revenue, by type (2019-2030)
- 12.3.3. Diagnostic market revenue, by type (2019-2030)
- 12.4. Market Revenue, by End User (2019-2030)
- 12.5. Market Revenue, by Country (2019-2030)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Market Revenue, by Type (2019-2030)
- 13.3. Market Revenue, by Application (2019-2030)
- 13.3.1. Therapeutic market revenue, by type (2019-2030)
- 13.3.2. Monitoring market revenue, by type (2019-2030)
- 13.3.3. Diagnostic market revenue, by type (2019-2030)
- 13.4. Market Revenue, by End User (2019-2030)
- 13.5. Market Revenue, by Application (2019-2030)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Market Revenue, by Type (2019-2030)
- 14.3. Market Revenue, by Application (2019-2030)
- 14.3.1. Therapeutic market revenue, by type (2019-2030)
- 14.3.2. Monitoring market revenue, by type (2019-2030)
- 14.3.3. Diagnostic market revenue, by type (2019-2030)
- 14.4. Market Revenue, by End User (2019-2030)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Market Revenue, by Type (2019-2030)
- 15.3. Market Revenue, by Application (2019-2030)
- 15.3.1. Therapeutic market revenue, by type (2019-2030)
- 15.3.2. Monitoring market revenue, by type (2019-2030)
- 15.3.3. Diagnostic market revenue, by type (2019-2030)
- 15.4. Market Revenue, by End User (2019-2030)
Chapter 16. France Market
- 16.1. Overview
- 16.2. Market Revenue, by Type (2019-2030)
- 16.3. Market Revenue, by Application (2019-2030)
- 16.3.1. Therapeutic market revenue, by type (2019-2030)
- 16.3.2. Monitoring market revenue, by type (2019-2030)
- 16.3.3. Diagnostic market revenue, by type (2019-2030)
- 16.4. Market Revenue, by End User (2019-2030)
Chapter 17. U.K. Market
- 17.1. Overview
- 17.2. Market Revenue, by Type (2019-2030)
- 17.3. Market Revenue, by Application (2019-2030)
- 17.3.1. Therapeutic market revenue, by type (2019-2030)
- 17.3.2. Monitoring market revenue, by type (2019-2030)
- 17.3.3. Diagnostic market revenue, by type (2019-2030)
- 17.4. Market Revenue, by End User (2019-2030)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Market Revenue, by Type (2019-2030)
- 18.3. Market Revenue, by Application (2019-2030)
- 18.3.1. Therapeutic market revenue, by type (2019-2030)
- 18.3.2. Monitoring market revenue, by type (2019-2030)
- 18.3.3. Diagnostic market revenue, by type (2019-2030)
- 18.4. Market Revenue, by End User (2019-2030)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Market Revenue, by Type (2019-2030)
- 19.3. Market Revenue, by Application (2019-2030)
- 19.3.1. Therapeutic market revenue, by type (2019-2030)
- 19.3.2. Monitoring market revenue, by type (2019-2030)
- 19.3.3. Diagnostic market revenue, by type (2019-2030)
- 19.4. Market Revenue, by End User (2019-2030)
Chapter 20. Japan Market
- 20.1. Overview
- 20.2. Market Revenue, by Type (2019-2030)
- 20.3. Market Revenue, by Application (2019-2030)
- 20.3.1. Therapeutic market revenue, by type (2019-2030)
- 20.3.2. Monitoring market revenue, by type (2019-2030)
- 20.3.3. Diagnostic market revenue, by type (2019-2030)
- 20.4. Market Revenue, by End User (2019-2030)
Chapter 21. China Market
- 21.1. Overview
- 21.2. Market Revenue, by Type (2019-2030)
- 21.3. Market Revenue, by Application (2019-2030)
- 21.3.1. Therapeutic market revenue, by type (2019-2030)
- 21.3.2. Monitoring market revenue, by type (2019-2030)
- 21.3.3. Diagnostic market revenue, by type (2019-2030)
- 21.4. Market Revenue, by End User (2019-2030)
Chapter 22. India Market
- 22.1. Overview
- 22.2. Market Revenue, by Type (2019-2030)
- 22.3. Market Revenue, by Application (2019-2030)
- 22.3.1. Therapeutic market revenue, by type (2019-2030)
- 22.3.2. Monitoring market revenue, by type (2019-2030)
- 22.3.3. Diagnostic market revenue, by type (2019-2030)
- 22.4. Market Revenue, by End User (2019-2030)
Chapter 23. Australia Market
- 23.1. Overview
- 23.2. Market Revenue, by Type (2019-2030)
- 23.3. Market Revenue, by Application (2019-2030)
- 23.3.1. Therapeutic market revenue, by type (2019-2030)
- 23.3.2. Monitoring market revenue, by type (2019-2030)
- 23.3.3. Diagnostic market revenue, by type (2019-2030)
- 23.4. Market Revenue, by End User (2019-2030)
Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Market Revenue, by Type (2019-2030)
- 24.3. Market Revenue, by Application (2019-2030)
- 24.3.1. Therapeutic market revenue, by type (2019-2030)
- 24.3.2. Monitoring market revenue, by type (2019-2030)
- 24.3.3. Diagnostic market revenue, by type (2019-2030)
- 24.4. Market Revenue, by End User (2019-2030)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Market Revenue, by Type (2019-2030)
- 25.3. Market Revenue, by Application (2019-2030)
- 25.3.1. Therapeutic market revenue, by type (2019-2030)
- 25.3.2. Monitoring market revenue, by type (2019-2030)
- 25.3.3. Diagnostic market revenue, by type (2019-2030)
- 25.4. Market Revenue, by End User (2019-2030)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Market Revenue, by Type (2019-2030)
- 26.3. Market Revenue, by Application (2019-2030)
- 26.3.1. Therapeutic market revenue, by type (2019-2030)
- 26.3.2. Monitoring market revenue, by type (2019-2030)
- 26.3.3. Diagnostic market revenue, by type (2019-2030)
- 26.4. Market Revenue, by End User (2019-2030)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Market Revenue, by Type (2019-2030)
- 27.3. Market Revenue, by Application (2019-2030)
- 27.3.1. Therapeutic market revenue, by type (2019-2030)
- 27.3.2. Monitoring market revenue, by type (2019-2030)
- 27.3.3. Diagnostic market revenue, by type (2019-2030)
- 27.4. Market Revenue, by End User (2019-2030)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Market Revenue, by Type (2019-2030)
- 28.3. Market Revenue, by Application (2019-2030)
- 28.3.1. Therapeutic market revenue, by type (2019-2030)
- 28.3.2. Monitoring market revenue, by type (2019-2030)
- 28.3.3. Diagnostic market revenue, by type (2019-2030)
- 28.4. Market Revenue, by End User (2019-2030)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Market Revenue, by Type (2019-2030)
- 29.3. Market Revenue, by Application (2019-2030)
- 29.3.1. Therapeutic market revenue, by type (2019-2030)
- 29.3.2. Monitoring market revenue, by type (2019-2030)
- 29.3.3. Diagnostic market revenue, by type (2019-2030)
- 29.4. Market Revenue, by End User (2019-2030)
Chapter 30. Company Profiles
- 30.1. Medtronic
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. ResMed
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Fisher & Paykel Healthcare Limited
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Teleflex Incorporated
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Hamilton Medical AG
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Dragerwerk AG & Co. KGaA
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Getinge
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. NIHON KOHDEN CORPORATION
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.